- EonC is the First Extended-Life Primary Cell Neurostimulator for the Treatment of Chronic Pain.
- The EonC neurostimulator provides a convenient option for chronic pain patients who prefer or require the simplicity of a non-rechargeable medical device.

Other headlines for [STJ]

• STJ Today 05:58am
  St Jude Medical Inc Price Target lowered to $42 from $52 at Merrill, maintains buy rating
  
• STJ Yesterday 05:05pm
  St Jude Medical Inc Guides Q4 EPS $0.56-0.66 v $0.61e, R $1.06-1.12B v $1.13Be- Guides FY 2009 EPS $2.47-2.52 (incl effect of foreign exchange) v $2.59e
  
• STJ 11/19/2008 07:24am
  St Jude Medical Inc Jefferies Initiates STJ with Hold, price target: $34
  
• STJ 11/17/2008 08:01am
  St Jude Medical Inc Japan approves Victory family of pacemakers, launches products in Japan- Victory pacemakers are engineered to accommodate a wide variety of the diagnostic and therapy needs of patients, including more...
  
• STJ 10/27/2008 08:30am
  St Jude Medical Inc Announces Publication of 20-Year Durability Data on Tissue Heart Valve- The Biocor valve was found to perform well on key measures of long-term performance including freedom from reoperation due to more...
  

Healthcare sector headlines

• NCST Today 09:48am
  Nucryst Pharmaceuticals Corp Majority holder calls for special meeting of shareholders to consider a return of capital of $0.80/shr
  
• GNBT Today 09:30am
  Generex Biotechnology Announces Positive Results of Metformin Chewing Gum Trial- Results of this fully compliant ICH-GCP conducted study indicate that the MetControl Metformin chewing gum and traditional Metformin tablets more...
  
• Today 09:30am
  Fed sets overnight reverse repos, accepts $25B
  
• 4568.JP Today 09:28am
  Daiichi Sankyo Co Three Studies of Oral Factor Xa Inhibitor DU-176b Accepted for the 50th Annual Meeting of the American Society of Hematology- Results from three studies of its investigational molecule, DU-176b, will more...
  
• GENZ Today 09:22am
  Genzyme Corp European Patent on cross-linked Gel Slurries has been revoked by EPO board of appeal- Announces that the opposition they filed against European Patent EP 0466300 B1 to Genzyme Corporation has been more...